Letter to Shareholders from the Chair (elect) Professor Jeffrey Rosenfeld 2023 Announcements . Corporate . News 14.12.2023
Sydney Soirée — CLINUVEL’s Phase III vitiligo program 2023 Announcements . Corporate . News 10.11.2023